Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2033 ARTÍCULOS , VIENDO DEL 106 AL 120

Use it or lose it

Rechnitz O, Derdikman D.

Elife. 2023 Jan 24;12:e85437. doi: 10.7554/eLife.85437.

Exploring the Role of Glycolytic Enzymes PFKFB3 and GAPDH in the Modulation of Aβ and Neurodegeneration and Their Potential of Therapeutic Targets in Alzheimer's Disease

Ahmad I, Singh R, Pal S, Prajapati S, Sachan N, Laiq Y, Husain H.

Appl Biochem Biotechnol. 2023 Jul;195(7):4673-4688. doi: 10.1007/s12010-023-04340-0. Epub 2023 Jan 24.

Defective proteostasis in Alzheimer's disease

Cozachenco D, Ribeiro FC, Ferreira ST.

Ageing Res Rev. 2023 Mar;85:101862. doi: 10.1016/j.arr.2023.101862. Epub 2023 Jan 21.

PSEN2 and ABCA7 variants causing early-onset preclinical pathological changes in Alzheimer's disease: a case report and literature review

Gan J, Zhou H, Liu C, Fang L.

Neurol Sci. 2023 Jun;44(6):1987-2001. doi: 10.1007/s10072-023-06602-5. Epub 2023 Jan 26.

Liquid-liquid phase separation of protein tau: An emerging process in Alzheimer's disease pathogenesis

Ainani H, Bouchmaa N, Ben Mrid R, El Fatimy R.

Neurobiol Dis. 2023 Mar;178:106011. doi: 10.1016/j.nbd.2023.106011. Epub 2023 Jan 23.

The shared molecular mechanisms underlying aging of the brain, major depressive disorder, and Alzheimer's disease: The role of circadian rhythm disturbances

Amidfar M, Garcez ML, Kim YK.

Prog Neuropsychopharmacol Biol Psychiatry. 2023 Apr 20;123:110721. doi: 10.1016/j.pnpbp.2023.110721. Epub 2023 Jan 23.

Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial

Yulug B, Altay O, Li X, Hanoglu L, Cankaya S, Lam S, Velioglu HA, Yang H, Coskun E, Idil E, Nogaylar R, Ozsimsek A, Bayram C, Bolat I, Oner S, Tozlu OO, Arslan ME, Hacimuftuoglu A, Yildirim S, Arif M, Shoaie S, Zhang C, Nielsen J, Turkez H, Borén J, Uhlén M, Mardinoglu A.

Transl Neurodegener. 2023 Jan 26;12(1):4. doi: 10.1186/s40035-023-00336-2.

The neuroimmune axis of Alzheimer's disease

Jorfi M, Maaser-Hecker A, Tanzi RE.

Genome Med. 2023 Jan 26;15(1):6. doi: 10.1186/s13073-023-01155-w.

Challenges and Opportunities of Metal Chelation Therapy in Trace Metals Overload-Induced Alzheimer's Disease

Chaudhari V, Bagwe-Parab S, Buttar HS, Gupta S, Vora A, Kaur G.

Neurotox Res. 2023 Jun;41(3):270-287. doi: 10.1007/s12640-023-00634-7. Epub 2023 Jan 27.

How does apolipoprotein E genotype influence the relationship between physical activity and Alzheimer's disease risk? A novel integrative model

de Frutos Lucas J, Sewell KR, García-Colomo A, Markovic S, Erickson KI, Brown BM.

Alzheimers Res Ther. 2023 Jan 27;15(1):22. doi: 10.1186/s13195-023-01170-4.

Brain temperature in healthy and diseased conditions: A review on the special implications of MRS for monitoring brain temperature

Yulug B, Velioglu HA, Sayman D, Cankaya S, Hanoglu L.

Biomed Pharmacother. 2023 Apr;160:114287. doi: 10.1016/j.biopha.2023.114287. Epub 2023 Jan 27.

Etiology and Clinical Significance of Network Hyperexcitability in Alzheimer's Disease: Unanswered Questions and Next Steps

Samudra N, Ranasinghe K, Kirsch H, Rankin K, Miller B.

J Alzheimers Dis. 2023;92(1):13-27. doi: 10.3233/JAD-220983.

The gut microbiome in Alzheimer's disease: what we know and what remains to be explored

Chandra S, Sisodia SS, Vassar RJ.

Mol Neurodegener. 2023 Feb 1;18(1):9. doi: 10.1186/s13024-023-00595-7.

Research progress of PPARγ regulation of cholesterol and inflammation in Alzheimer's disease

Gu L, Ju Y, Hu M, Zheng M, Li Q, Zhang X.

Metab Brain Dis. 2023 Mar;38(3):839-854. doi: 10.1007/s11011-022-01139-6. Epub 2023 Feb 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias